<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Array BioPharma, Inc. v. Eugia Pharma Specialities Limited et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2022cv01236/80106</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2022cv01236/80106/feed" rel="self" type="application/rss+xml" />
        <pubDate>Sat, 14 Nov 2026 15:40:30 -0800</pubDate>
        <lastBuildDate>Sat, 14 Nov 2026 15:40:30 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Array BioPharma, Inc. v. Eugia Pharma Specialities Limited et al - Docket Entries - Showing 1 through 14</description>
                                    <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary") Ji - filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Limited. (Neff, Carl) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718119</guid>
                <pubDate>
            Thu, 17 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                ORDER granting #12 Motion to Appear Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D. Signed by Judge William C. Bryson on 11/17/2022. (srs) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718118</guid>
                <pubDate>
            Thu, 17 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D. - filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Limited. (Neff, Carl) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718117</guid>
                <pubDate>
            Thu, 17 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Gurpreet S. Walia for Aurobindo Pharma USA, Inc.,Gurpreet S. Walia for Eugia Pharma Specialities Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718120</guid>
                <pubDate>
            Thu, 17 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718116</guid>
                <pubDate>
            Tue, 15 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED re #11 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the complaint to December 19, 2022 (Set/Reset Answer Deadlines: Aurobindo Pharma USA, Inc. answer due 12/19/2022; Eugia Pharma Specialities Limited answer due 12/19/2022). ORDERED by Judge Maryellen Noreika on 10/14/2022. (dlw) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718115</guid>
                <pubDate>
            Fri, 14 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to ANSWER complaint to December 19, 2022 - filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Limited. (Neff, Carl) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718114</guid>
                <pubDate>
            Thu, 13 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Carl Douglas Neff on behalf of All Defendants (Neff, Carl) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718113</guid>
                <pubDate>
            Thu, 13 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                AFFIDAVIT of Service for Summons, Complaint and related papers served on Eugia Pharma Specialities Limited on September 29, 2022, filed by Array BioPharma, Inc.. (Dellinger, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718112</guid>
                <pubDate>
            Fri, 30 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                SUMMONS Returned Executed by Array BioPharma, Inc..Aurobindo Pharma USA, Inc. served on 9/29/2022, answer due 10/20/2022. (Dellinger, Megan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718111</guid>
                <pubDate>
            Fri, 30 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_18718110</guid>
                <pubDate>
            Wed, 28 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 9, 2022. Date of Expiration of Patent: August 5, 2033.Thirty Month Stay Deadline: 12/27/2025. (Blumenfeld, Jack) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777535</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Aurobindo Pharma USA, Inc. on 9/22/2022; Eugia Pharma Specialities Limited on 9/22/2022. (Attachments: #1 Summons Issued)(mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777534</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Array BioPharma, Inc. filed by Array BioPharma, Inc.. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777533</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,474,754 B2. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777532</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/09/2022. Date of Expiration of Patent: 08/05/2033.Thirty Month Stay Deadline: 2/9/2025. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777531</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777530</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Limited ( Filing fee $ 402, receipt number ADEDC-3964846.) - filed by Array BioPharma, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17777529</guid>
                <pubDate>
            Thu, 22 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
